Document Classification

Section Type: RESULTS

Text: More patients in the MMC group had relief of symptoms like redness [25 (80. 7 %) in the MMC group versus 19 (55. 9 %) in the azelastine group ; p = 0. 033], photophobia [11 (35. 5 %) in the MMC group versus six (17. 7 %) in the azelastine group ; not significant], discharge [17 (54. 8 %) in the MMC group versus 11 (32. 3 %) in the azelastine group ; not significant], and foreign body sensation [21 (67. 7 %) in the MMC group versus 16 (47. 1 %) in the azelastine group ; not significant], while more patients in the azelastine group had relief of lacrimation [14 (41. 2 %) in the azelastine group versus 10 (32. 3 %) in the MMC group ; not significant] and pain [12 (35. 3 %) in the azelastine group versus eight (25. 8 %) in the MMC group ; not significant].